Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

The Galleria mellonella Infection Model for Investigating the Molecular Mechanisms of Legionella Virulence.

Frankel G, Schroeder GN.

Methods Mol Biol. 2019;1921:333-346. doi: 10.1007/978-1-4939-9048-1_22.

PMID:
30694503
2.

Determination of In Vivo Interactomes of Dot/Icm Type IV Secretion System Effectors by Tandem Affinity Purification.

So EC, Mousnier A, Frankel G, Schroeder GN.

Methods Mol Biol. 2019;1921:289-303. doi: 10.1007/978-1-4939-9048-1_19.

PMID:
30694500
3.

More than 18,000 effectors in the Legionella genus genome provide multiple, independent combinations for replication in human cells.

Gomez-Valero L, Rusniok C, Carson D, Mondino S, Pérez-Cobas AE, Rolando M, Pasricha S, Reuter S, Demirtas J, Crumbach J, Descorps-Declere S, Hartland EL, Jarraud S, Dougan G, Schroeder GN, Frankel G, Buchrieser C.

Proc Natl Acad Sci U S A. 2019 Feb 5;116(6):2265-2273. doi: 10.1073/pnas.1808016116. Epub 2019 Jan 18.

4.

The Legionella effector LtpM is a new type of phosphoinositide-activated glucosyltransferase.

Levanova N, Mattheis C, Carson D, To KN, Jank T, Frankel G, Aktories K, Schroeder GN.

J Biol Chem. 2019 Feb 22;294(8):2862-2879. doi: 10.1074/jbc.RA118.005952. Epub 2018 Dec 20.

5.

The Toolbox for Uncovering the Functions of Legionella Dot/Icm Type IVb Secretion System Effectors: Current State and Future Directions.

Schroeder GN.

Front Cell Infect Microbiol. 2018 Jan 5;7:528. doi: 10.3389/fcimb.2017.00528. eCollection 2017. Review.

6.

Erratum: EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation.

Pearson JS, Giogha C, Mühlen S, Nachbur U, Pham CL, Zhang Y, Hildebrand JM, Oates CV, Lung TW, Ingle D, Dagley LF, Bankovacki A, Petrie EJ, Schroeder GN, Crepin VF, Frankel G, Masters SL, Vince J, Murphy JM, Sunde M, Webb AI, Silke J, Hartland EL.

Nat Microbiol. 2017 Feb 13;2:17024. doi: 10.1038/nmicrobiol.2017.24. No abstract available.

7.

EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation.

Pearson JS, Giogha C, Mühlen S, Nachbur U, Pham CL, Zhang Y, Hildebrand JM, Oates CV, Lung TW, Ingle D, Dagley LF, Bankovacki A, Petrie EJ, Schroeder GN, Crepin VF, Frankel G, Masters SL, Vince J, Murphy JM, Sunde M, Webb AI, Silke J, Hartland EL.

Nat Microbiol. 2017 Jan 13;2:16258. doi: 10.1038/nmicrobiol.2016.258. Erratum in: Nat Microbiol. 2017 Feb 13;2:17024.

8.

The Rab-binding Profiles of Bacterial Virulence Factors during Infection.

So EC, Schroeder GN, Carson D, Mattheis C, Mousnier A, Broncel M, Tate EW, Frankel G.

J Biol Chem. 2016 Mar 11;291(11):5832-43. doi: 10.1074/jbc.M115.700930. Epub 2016 Jan 11.

9.

Legionella pneumophila Effector LpdA Is a Palmitoylated Phospholipase D Virulence Factor.

Schroeder GN, Aurass P, Oates CV, Tate EW, Hartland EL, Flieger A, Frankel G.

Infect Immun. 2015 Oct;83(10):3989-4002. doi: 10.1128/IAI.00785-15. Epub 2015 Jul 27.

10.

Creating a customized intracellular niche: subversion of host cell signaling by Legionella type IV secretion system effectors.

So EC, Mattheis C, Tate EW, Frankel G, Schroeder GN.

Can J Microbiol. 2015 Sep;61(9):617-35. doi: 10.1139/cjm-2015-0166. Epub 2015 May 6.

11.

A new method to determine in vivo interactomes reveals binding of the Legionella pneumophila effector PieE to multiple rab GTPases.

Mousnier A, Schroeder GN, Stoneham CA, So EC, Garnett JA, Yu L, Matthews SJ, Choudhary JS, Hartland EL, Frankel G.

MBio. 2014 Aug 12;5(4). pii: e01148-14. doi: 10.1128/mBio.01148-14.

12.

Use of Galleria mellonella as a model organism to study Legionella pneumophila infection.

Harding CR, Schroeder GN, Collins JW, Frankel G.

J Vis Exp. 2013 Nov 22;(81):e50964. doi: 10.3791/50964.

13.

LtpD is a novel Legionella pneumophila effector that binds phosphatidylinositol 3-phosphate and inositol monophosphatase IMPA1.

Harding CR, Mattheis C, Mousnier A, Oates CV, Hartland EL, Frankel G, Schroeder GN.

Infect Immun. 2013 Nov;81(11):4261-70. doi: 10.1128/IAI.01054-13. Epub 2013 Sep 3.

14.

The Dot/Icm effector SdhA is necessary for virulence of Legionella pneumophila in Galleria mellonella and A/J mice.

Harding CR, Stoneham CA, Schuelein R, Newton H, Oates CV, Hartland EL, Schroeder GN, Frankel G.

Infect Immun. 2013 Jul;81(7):2598-605. doi: 10.1128/IAI.00296-13. Epub 2013 May 6.

15.

The Legionella pneumophila Dot/Icm-secreted effector PlcC/CegC1 together with PlcA and PlcB promotes virulence and belongs to a novel zinc metallophospholipase C family present in bacteria and fungi.

Aurass P, Schlegel M, Metwally O, Harding CR, Schroeder GN, Frankel G, Flieger A.

J Biol Chem. 2013 Apr 19;288(16):11080-92. doi: 10.1074/jbc.M112.426049. Epub 2013 Mar 1.

16.

Legionella pneumophila pathogenesis in the Galleria mellonella infection model.

Harding CR, Schroeder GN, Reynolds S, Kosta A, Collins JW, Mousnier A, Frankel G.

Infect Immun. 2012 Aug;80(8):2780-90. doi: 10.1128/IAI.00510-12. Epub 2012 May 29.

17.

BopC is a type III secreted effector protein of Burkholderia pseudomallei.

Muangman S, Korbsrisate S, Muangsombut V, Srinon V, Adler NL, Schroeder GN, Frankel G, Galyov EE.

FEMS Microbiol Lett. 2011 Oct;323(1):75-82. doi: 10.1111/j.1574-6968.2011.02359.x. Epub 2011 Aug 10.

18.

Salmonella bongori provides insights into the evolution of the Salmonellae.

Fookes M, Schroeder GN, Langridge GC, Blondel CJ, Mammina C, Connor TR, Seth-Smith H, Vernikos GS, Robinson KS, Sanders M, Petty NK, Kingsley RA, Bäumler AJ, Nuccio SP, Contreras I, Santiviago CA, Maskell D, Barrow P, Humphrey T, Nastasi A, Roberts M, Frankel G, Parkhill J, Dougan G, Thomson NR.

PLoS Pathog. 2011 Aug;7(8):e1002191. doi: 10.1371/journal.ppat.1002191. Epub 2011 Aug 18.

19.

Legionella pneumophila strain 130b possesses a unique combination of type IV secretion systems and novel Dot/Icm secretion system effector proteins.

Schroeder GN, Petty NK, Mousnier A, Harding CR, Vogrin AJ, Wee B, Fry NK, Harrison TG, Newton HJ, Thomson NR, Beatson SA, Dougan G, Hartland EL, Frankel G.

J Bacteriol. 2010 Nov;192(22):6001-16. doi: 10.1128/JB.00778-10. Epub 2010 Sep 10.

20.

Binding to Na(+) /H(+) exchanger regulatory factor 2 (NHERF2) affects trafficking and function of the enteropathogenic Escherichia coli type III secretion system effectors Map, EspI and NleH.

Martinez E, Schroeder GN, Berger CN, Lee SF, Robinson KS, Badea L, Simpson N, Hall RA, Hartland EL, Crepin VF, Frankel G.

Cell Microbiol. 2010 Dec;12(12):1718-31. doi: 10.1111/j.1462-5822.2010.01503.x.

21.

The Citrobacter rodentium genome sequence reveals convergent evolution with human pathogenic Escherichia coli.

Petty NK, Bulgin R, Crepin VF, Cerdeño-Tárraga AM, Schroeder GN, Quail MA, Lennard N, Corton C, Barron A, Clark L, Toribio AL, Parkhill J, Dougan G, Frankel G, Thomson NR.

J Bacteriol. 2010 Jan;192(2):525-38. doi: 10.1128/JB.01144-09. Epub 2009 Nov 6.

22.

Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion.

Schroeder GN, Hilbi H.

Clin Microbiol Rev. 2008 Jan;21(1):134-56. doi: 10.1128/CMR.00032-07. Review.

23.
24.

Cholesterol is required to trigger caspase-1 activation and macrophage apoptosis after phagosomal escape of Shigella.

Schroeder GN, Hilbi H.

Cell Microbiol. 2007 Jan;9(1):265-78. Epub 2006 Aug 22.

PMID:
16925787
25.

Mutational analysis of a type II thioesterase associated with nonribosomal peptide synthesis.

Linne U, Schwarzer D, Schroeder GN, Marahiel MA.

Eur J Biochem. 2004 Apr;271(8):1536-45.

Supplemental Content

Loading ...
Support Center